Corrigendum to “Inhibition of thioredoxin reductase by alantolactone prompts oxidative stress-mediated apoptosis of HeLa cells” [Biochem. Pharmacol. 102 (2016) 34–44, (S0006295215007595), (10.1016/j.bcp.2015.12.004)];Inhibition of thioredoxin reductase by alantolactone prompts oxidative stress-mediated apoptosis of HeLa cells

Biochemical Pharmacology

Volumn 102, Issue , 2016, Pages 34-44

  Zhang, Junmin ^a   Li, Ya ^a   Duan, Dongzhu ^a   Yao, Juan ^a   Gao, Kun ^a   Fang, Jianguo ^a  

^a LANZHOU UNIVERSITY   (China)

Author keywords

Alantolactone; Apoptosis; Oxidative stress; Redox regulation; Thioredoxin reductase

Indexed keywords

ALANTOLACTONE; CASPASE 3; CYTOTOXIC AGENT; GLUTATHIONE; OXIDOREDUCTASE INHIBITOR; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SELENOCYSTEINE; THIOREDOXIN; THIOREDOXIN REDUCTASE; ENZYME INHIBITOR; LACTONE; SESQUITERPENE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL DEATH; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; ENZYME INHIBITION; FEMALE; GENE OVEREXPRESSION; HELA CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN TARGETING; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL SURVIVAL; DRUG EFFECTS; HEK293 CELL LINE; HEPG2 CELL LINE; HL 60 CELL LINE; METABOLISM; PHYSIOLOGY; RAT;

ANIMALS; APOPTOSIS; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; HEK293 CELLS; HELA CELLS; HEP G2 CELLS; HL-60 CELLS; HUMANS; LACTONES; OXIDATIVE STRESS; RATS; SESQUITERPENES, EUDESMANE; THIOREDOXIN-DISULFIDE REDUCTASE;

EID: 84958778851     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2024.116317     Document Type: Erratum

References (70)

1. D.G. Kingston Modern natural products drug discovery and its relevance to biodiversity conservation J. Nat. Prod. 74 2011 496 511
2. J.W. Li, and J.C. Vederas Drug discovery and natural products: end of an era or an endless frontier? Science 325 2009 161 165
3. I. Merfort Perspectives on sesquiterpene lactones in inflammation and cancer Curr. Drug Targets 12 2011 1560 1573
4. S. Zhang, Y.K. Won, C.N. Ong, and H.M. Shen Anti-cancer potential of sesquiterpene lactones: bioactivity and molecular mechanisms Curr. Med. Chem. 5 2005 239 249
5. G.W. Wang, J.J. Qin, X.R. Cheng, Y.H. Shen, L. Shan, H.Z. Jin, and et al. Inula sesquiterpenoids: structural diversity, cytotoxicity and anti-tumor activity Expert Opin. Investig. Drugs 23 2014 317 345
6. J. Wang, Y.M. Zhao, M.L. Zhang, and Q.W. Shi Simultaneous determination of chlorogenic acid, caffeic acid, alantolactone and isoalantolactone in Inula helenium by HPLC J. Chromatogr. Sci. 53 2014 526 530
7. T. Konishi, Y. Shimada, T. Nagao, H. Okabe, and T. Konoshima Antiproliferative sesquiterpene lactones from the roots of Inula helenium Biol. Pharm. Bull. 25 2002 1370 1372
8. C.L. Cantrell, L. Abate, F.R. Fronczek, S.G. Franzblau, L. Quijano, and N.H. Fischer Antimycobacterial eudesmanolides from Inula helenium and Rudbeckia subtomentosa Planta Med. 65 1999 351 355
9. J.Y. Seo, S.S. Lim, J.R. Kim, J.S. Lim, Y.R. Ha, I.A. Lee, and et al. Nrf2-mediated induction of detoxifying enzymes by alantolactone present in Inula helenium Phytother. Res. 22 2008 1500 1505
10. J. Chun, R.J. Choi, S. Khan, D.S. Lee, Y.C. Kim, Y.J. Nam, and et al. Alantolactone suppresses inducible nitric oxide synthase and cyclooxygenase-2 expression by down-regulating NF-kappaB, MAPK and AP-1 via the MyD88 signaling pathway in LPS-activated RAW 264.7 cells Int. Immunopharmacol. 14 2012 375 383
11. H.S. Lim, S.E. Jin, O.S. Kim, H.K. Shin, and S.J. Jeong Alantolactone from Saussurea lappa exerts antiinflammatory effects by inhibiting chemokine production and STAT1 phosphorylation in TNF-alpha and IFN-gamma-induced in HaCaT cells Phytother. Res. 29 2015 1088 1096
12. J.C. Lei, J.Q. Yu, Y. Yin, Y.W. Liu, and G.L. Zou Alantolactone induces activation of apoptosis in human hepatoma cells Food Chem. Toxicol. 50 2012 3313 3319
13. J. Chun, R.J. Li, M.S. Cheng, and Y.S. Kim Alantolactone selectively suppresses STAT3 activation and exhibits potent anticancer activity in MDA-MB-231 cells Cancer Lett. 357 2015 393 403
14. X.G. Mi, Z.B. Song, P. Wu, Y.W. Zhang, L.G. Sun, Y.L. Bao, and et al. Alantolactone induces cell apoptosis partially through down-regulation of testes-specific protease 50 expression Toxicol. Lett. 224 2014 349 355
15. M. Khan, F. Yi, A. Rasul, T. Li, N. Wang, H. Gao, and et al. Alantolactone induces apoptosis in glioblastoma cells via GSH depletion, ROS generation, and mitochondrial dysfunction IUBMB Life 64 2012 783 794
16. W. Wei, H. Huang, S. Zhao, W. Liu, C.X. Liu, L. Chen, and et al. Alantolactone induces apoptosis in chronic myelogenous leukemia sensitive or resistant to imatinib through NF-kappaB inhibition and Bcr/Abl protein deletion Apoptosis 18 2013 1060 1070
17. Y. Shi, Y.L. Bao, Y. Wu, C.L. Yu, Y.X. Huang, Y. Sun, and et al. Alantolactone inhibits cell proliferation by interrupting the interaction between Cripto-1 and activin receptor type II A in activin signaling pathway J. Biomol. Screen. 16 2011 525 535
18. A. Bindoli, and M.P. Rigobello Principles in redox signaling: from chemistry to functional significance Antioxid. Redox Signal. 18 2013 1557 1593
19. E.S. Arner Focus on mammalian thioredoxin reductases - important selenoproteins with versatile functions Biochim. Biophys. Acta 1790 2009 495 526
20. J. Lu, and A. Holmgren The thioredoxin antioxidant system Free Radic. Biol. Med. 66 2014 75 87
21. H.J. Forman, F. Ursini, and M. Maiorino An overview of mechanisms of redox signaling J. Mol. Cell. Cardiol. 73 2014 2 9
22. E.M. Hanschmann, J.R. Godoy, C. Berndt, C. Hudemann, and C.H. Lillig Thioredoxins, glutaredoxins, and peroxiredoxins-molecular mechanisms and health significance: from cofactors to antioxidants to redox signaling Antioxid. Redox Signal. 19 2013 1539 1605
23. D.F. Mahmood, A. Abderrazak, E.H. Khadija, T. Simmet, and M. Rouis The thioredoxin system as a therapeutic target in human health and disease Antioxid. Redox Signal. 19 2013 1266 1303
24. D.T. Lincoln, E.M. Ali Emadi, K.F. Tonissen, and F.M. Clarke The thioredoxin-thioredoxin reductase system: over-expression in human cancer Anticancer Res. 23 2003 2425 2433
25. K. Kahlos, Y. Soini, M. Saily, P. Koistinen, S. Kakko, P. Paakko, and et al. Up-regulation of thioredoxin and thioredoxin reductase in human malignant pleural mesothelioma Int. J. Cancer 95 2001 198 204
26. M. Berggren, A. Gallegos, J.R. Gasdaska, P.Y. Gasdaska, J. Warneke, and G. Powis Thioredoxin and thioredoxin reductase gene expression in human tumors and cell lines, and the effects of serum stimulation and hypoxia Anticancer Res. 16 1996 3459 3466
27. J. Hellfritsch, J. Kirsch, M. Schneider, T. Fluege, M. Wortmann, J. Frijhoff, and et al. Knockout of mitochondrial thioredoxin reductase stabilizes prolyl hydroxylase 2 and inhibits tumor growth and tumor-derived angiogenesis Antioxid. Redox Signal. 22 2015 938 950
28. M.H. Yoo, X.M. Xu, B.A. Carlson, V.N. Gladyshev, and D.L. Hatfield Thioredoxin reductase 1 deficiency reverses tumor phenotype and tumorigenicity of lung carcinoma cells J. Biol. Chem. 281 2006 13005 13008
29. S.J. Welsh, W.T. Bellamy, M.M. Briehl, and G. Powis The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis Cancer Res. 62 2002 5089 5095
30. Y. Chen, J. Cai, T.J. Murphy, and D.P. Jones Overexpressed human mitochondrial thioredoxin confers resistance to oxidant-induced apoptosis in human osteosarcoma cells J. Biol. Chem. 277 2002 33242 33248
31. A. Baker, C.M. Payne, M.M. Briehl, and G. Powis Thioredoxin, a gene found overexpressed in human cancer, inhibits apoptosis in vitro and in vivo Cancer Res. 57 1997 5162 5167
32. B. Zhang, D. Duan, C. Ge, J. Yao, Y. Liu, X. Li, and et al. Synthesis of xanthohumol analogues and discovery of potent thioredoxin reductase inhibitor as potential anticancer agent J. Med. Chem. 58 2015 1795 1805
33. F. Dai, G.Y. Liu, Y. Li, W.J. Yan, Q. Wang, J. Yang, and et al. Insights into the importance for designing curcumin-inspired anticancer agents by a prooxidant strategy: the case of diarylpentanoids Free Radic. Biol. Med. 85 2015 127 137
34. A. Citta, A. Folda, A. Bindoli, P. Pigeon, S. Top, A. Vessieres, and et al. Evidence for targeting thioredoxin reductases with ferrocenyl quinone methides. A possible molecular basis for the antiproliferative effect of hydroxyferrocifens on cancer cells J. Med. Chem. 57 2014 8849 8859
35. X. Peng, M.Q. Zhang, F. Conserva, G. Hosny, G. Selivanova, V.J. Bykov, and et al. APR-246/PRIMA-1MET inhibits thioredoxin reductase 1 and converts the enzyme to a dedicated NADPH oxidase Cell Death Dis. 4 2013 e881
36. F.F. Gan, K.K. Kaminska, H. Yang, C.Y. Liew, P.C. Leow, C.L. So, and et al. Identification of Michael acceptor-centric pharmacophores with substituents that yield strong thioredoxin reductase inhibitory character correlated to antiproliferative activity Antioxid. Redox Signal. 19 2013 1149 1165
37. W. Cai, L. Zhang, Y. Song, B. Wang, B. Zhang, X. Cui, and et al. Small molecule inhibitors of mammalian thioredoxin reductase Free Radic. Biol. Med. 52 2012 257 265
38. W. Cai, B. Zhang, D. Duan, J. Wu, and J. Fang Curcumin targeting the thioredoxin system elevates oxidative stress in HeLa cells Toxicol. Appl. Pharmacol. 262 2012 341 348
39. S. Prast-Nielsen, T.S. Dexheimer, L. Schultz, W.C. Stafford, Q. Cheng, J. Xu, and et al. Inhibition of thioredoxin reductase 1 by porphyrins and other small molecules identified by a high-throughput screening assay Free Radic. Biol. Med. 50 2011 1114 1123
40. Y. Liu, D. Duan, J. Yao, B. Zhang, S. Peng, H. Ma, and et al. Dithiaarsanes induce oxidative stress-mediated apoptosis in HL-60 cells by selectively targeting thioredoxin reductase J. Med. Chem. 57 2014 5203 5211
41. D. Duan, B. Zhang, J. Yao, Y. Liu, J. Sun, C. Ge, and et al. Gambogic acid induces apoptosis in hepatocellular carcinoma SMMC-7721 cells by targeting cytosolic thioredoxin reductase Free Radic. Biol. Med. 69 2014 15 25
42. D. Duan, B. Zhang, J. Yao, Y. Liu, and J. Fang Shikonin targets cytosolic thioredoxin reductase to induce ROS-mediated apoptosis in human promyelocytic leukemia HL-60 cells Free Radic. Biol. Med. 70 2014 182 193
43. B. Zhang, C. Ge, J. Yao, Y. Liu, H. Xie, and J. Fang Selective selenol fluorescent probes: design, synthesis, structural determinants, and biological applications J. Am. Chem. Soc. 137 2015 757 769
44. S. Peng, B. Zhang, X. Meng, J. Yao, and J. Fang Synthesis of piperlongumine analogues and discovery of nuclear factor erythroid 2-related factor 2 (Nrf2) activators as potential neuroprotective agents J. Med. Chem. 58 2015 5242 5255
45. E.S. Arner, H. Sarioglu, F. Lottspeich, A. Holmgren, and A. Bock High-level expression in Escherichia coli of selenocysteine-containing rat thioredoxin reductase utilizing gene fusions with engineered bacterial-type SECIS elements and co-expression with the selA, selB and selC genes J. Mol. Biol. 292 1999 1003 1016
46. P. Javvadi, L. Hertan, R. Kosoff, T. Datta, J. Kolev, R. Mick, and et al. Thioredoxin reductase-1 mediates curcumin-induced radiosensitization of squamous carcinoma cells Cancer Res. 70 2010 1941 1950
47. I. Nalvarte, A.E. Damdimopoulos, C. Nystom, T. Nordman, A. Miranda-Vizuete, J.M. Olsson, and et al. Overexpression of enzymatically active human cytosolic and mitochondrial thioredoxin reductase in HEK-293 cells. Effect on cell growth and differentiation J. Biol. Chem. 279 2004 54510 54517
48. Y.Y. Ma, D.G. Zhao, and K. Gao Structural investigation and biological activity of sesquiterpene lactones from the traditional Chinese herb Inula racemosa J. Nat. Prod. 76 2013 564 570
49. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 72 1976 248 254
50. L. Zhang, D. Duan, Y. Liu, C. Ge, X. Cui, J. Sun, and et al. Highly selective off-on fluorescent probe for imaging thioredoxin reductase in living cells J. Am. Chem. Soc. 136 2014 226 233
51. J. Yao, B. Zhang, C. Ge, S. Peng, and J. Fang Xanthohumol, a polyphenol chalcone present in hops, activating Nrf2 enzymes to confer protection against oxidative damage in PC12 cells J. Agric. Food Chem. 63 2015 1521 1531
52. Q. Cheng, L. Johansson, J.O. Thorell, A. Fredriksson, E. Samen, S. Stone-Elander, and et al. Selenolthiol and dithiol C-terminal tetrapeptide motifs for one-step purification and labeling of recombinant proteins produced in E. coli ChemBioChem 7 2006 1976 1981
53. L. Johansson, C. Chen, J.O. Thorell, A. Fredriksson, S. Stone-Elander, G. Gafvelin, and et al. Exploiting the 21st amino acid-purifying and labeling proteins by selenolate targeting Nat. Methods 1 2004 61 66
54. X. Qiu, Z. Liu, W.Y. Shao, X. Liu, D.P. Jing, Y.J. Yu, and et al. Synthesis and evaluation of curcumin analogues as potential thioredoxin reductase inhibitors Bioorg. Med. Chem. 16 2008 8035 8041
55. E.H. Chew, A.A. Nagle, Y. Zhang, S. Scarmagnani, P. Palaniappan, T.D. Bradshaw, and et al. Cinnamaldehydes inhibit thioredoxin reductase and induce Nrf2: potential candidates for cancer therapy and chemoprevention Free Radic. Biol. Med. 48 2010 98 111
56. B. Kalyanaraman, V. Darley-Usmar, K.J.A. Davies, P.A. Dennery, H.J. Forman, M.B. Grisham, and et al. Measuring reactive oxygen and nitrogen species with fluorescent probes: challenges and limitations Free Radic. Biol. Med. 52 2012 1 6
57. H. Zhang, and H.J. Forman Glutathione synthesis and its role in redox signaling Semin. Cell Dev. Biol. 23 2012 722 728
58. Y. Du, H. Zhang, J. Lu, and A. Holmgren Glutathione and glutaredoxin act as a backup of human thioredoxin reductase 1 to reduce thioredoxin 1 preventing cell death by aurothioglucose J. Biol. Chem. 287 2012 38210 38219
59. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 2011 646 674
60. M. Khan, T. Li, M.K. Ahmad Khan, A. Rasul, F. Nawaz, M. Sun, and et al. Alantolactone induces apoptosis in HepG2 cells through GSH depletion, inhibition of STAT3 activation, and mitochondrial dysfunction Biomed. Res. Int. 2013 2013 719858
61. C. Gorrini, I.S. Harris, and T.W. Mak Modulation of oxidative stress as an anticancer strategy Nat. Rev. Drug Discov. 12 2013 931 947
62. D. Trachootham, J. Alexandre, and P. Huang Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat. Rev. Drug Discov. 8 2009 579 591
63. J. Nordberg, and E.S. Arner Reactive oxygen species, antioxidants, and the mammalian thioredoxin system Free Radic. Biol. Med. 31 2001 1287 1312
64. M. Saitoh, H. Nishitoh, M. Fujii, K. Takeda, K. Tobiume, Y. Sawada, and et al. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1 EMBO J. 17 1998 2596 2606
65. S.B. Shelar, K.K. Kaminska, S.A. Reddy, D. Kumar, C.T. Tan, V.C. Yu, and et al. Thioredoxin-dependent regulation of AIF-mediated DNA damage Free Radic. Biol. Med. 87 2015 125 136
66. J.R. Matthews, N. Wakasugi, J.L. Virelizier, J. Yodoi, and R.T. Hay Thioredoxin regulates the DNA binding activity of NF-kappa B by reduction of a disulphide bond involving cysteine 62 Nucl. Acids Res. 20 1992 3821 3830
67. K. Hirota, M. Matsui, S. Iwata, A. Nishiyama, K. Mori, and J. Yodoi AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1 Proc. Natl. Acad. Sci. U. S. A. 94 1997 3633 3638
68. M. Ueno, H. Masutani, R.J. Arai, A. Yamauchi, K. Hirota, T. Sakai, and et al. Thioredoxin-dependent redox regulation of p53-mediated p21 activation J. Biol. Chem. 274 1999 35809 35815
69. K. Anestal, S. Prast-Nielsen, N. Cenas, and E.S. Arner Cell death by SecTRAPs: thioredoxin reductase as a prooxidant killer of cells PLoS One 3 2008 e1846
70. S.M. Kanzok, A. Fechner, H. Bauer, J.K. Ulschmid, H.M. Muller, J. Botella-Munoz, and et al. Substitution of the thioredoxin system for glutathione reductase in Drosophila melanogaster Science 291 2001 643 646